Literature DB >> 17680219

Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites. Technical considerations and results.

Masaharu Hata1, Koichi Tokuuye, Shinji Sugahara, Eriko Tohno, Nobuyoshi Fukumitsu, Takayuki Hashimoto, Kayoko Ohnishi, Keiko Nemoto, Kiyoshi Ohara, Takeji Sakae, Yasuyuki Akine.   

Abstract

PURPOSE: To present technical considerations and results of proton irradiation in a single fraction for hepatocellular carcinoma (HCC) patients with uncontrollable ascites. PATIENTS AND METHODS: Three HCC patients with uncontrollable ascites underwent proton irradiation of 24 Gy in a single fraction. Hepatic tumors were solitary in two patients, and multiple in one, and tumor sizes were 30, 30, and 33 mm in maximum diameter. No patient had lymph node or distant metastases. The center position of radiation fields was determined and the beam range was adjusted, using CT data taken immediately before irradiation to compensate for changes in the volume of ascites. Adjustment of the beam range was within 6 mm in water-equivalent thickness.
RESULTS: All irradiated tumors showed objective responses, and were controlled during the follow-up period. Of the three patients, two were alive with no evidence of disease at 13 and 30 months, respectively, after treatment. The remaining patient died of ruptured esophageal varices 6 months after treatment. No therapy-related toxicity of grade 3 or more was observed.
CONCLUSION: Proton beams were successfully adjusted immediately before irradiation. Single-dose irradiation with precisely adjusted proton beams may be tolerable for HCC patients with uncontrollable ascites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680219     DOI: 10.1007/s00066-007-1640-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  8 in total

1.  RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma.

Authors:  G Z Gong; Y Yin; L G Xing; Y J Guo; T Liu; J Chen; J Lu; C Ma; T Sun; T Bai; G Zhang; R Wang
Journal:  Strahlenther Onkol       Date:  2012-02-08       Impact factor: 3.621

Review 2.  Review of clinical experience with ion beam radiotherapy.

Authors:  A D Jensen; M W Münter; J Debus
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

Review 3.  Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 4.  Proton Therapy in the Management of Hepatocellular Carcinoma.

Authors:  Jana M Kobeissi; Lara Hilal; Charles B Simone; Haibo Lin; Christopher H Crane; Carla Hajj
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

5.  Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.

Authors:  Shinji Sugahara; Hidetsugu Nakayama; Kuniaki Fukuda; Masashi Mizumoto; Mari Tokita; Masato Abei; Junichi Shoda; Yasushi Matsuzaki; Eriko Thono; Koji Tsuboi; Koichi Tokuuye
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

6.  Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.

Authors:  Vivek Verma; Steven H Lin; Charles B Simone; Minesh P Mehta
Journal:  J Gastrointest Oncol       Date:  2016-08

7.  Effect of irradiation on gene expression of rat liver adhesion molecules: in vivo and in vitro studies.

Authors:  Federico Moriconi; Ihtzaz Malik; Ghayyor Ahmad; Joszef Dudas; Margret Rave-Fränk; Hilke Vorwerk; Andrea Hille; Clemens Friedrich Hess; Giuliano Ramadori; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

8.  Retracted article: In vitro derivation of mammalian germ cells from stem cells and their potential therapeutic application.

Authors:  Shigeo Saito; Ying-Chu Lin; Yoshinobu Murayama; Yukio Nakamura; Richard Eckner; Heiner Niemann; Kazunari K Yokoyama
Journal:  Cell Mol Life Sci       Date:  2015-10-06       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.